Engineering Solutions for Microbial Resistance in Medicine

The growing threat of microbial resistance (MR) poses a grave challenge to global healthcare, agriculture, and food safety systems. This paper examines engineering-based strategies and technological innovations aimed at mitigating microbial resistance in medical contexts. It begins by examining the mechanisms through which bacteria develop resistance, including genetic, biochemical, and environmental factors, particularly focusing on biofilm formation and antibiotic resistance gene (ARG) dissemination. The review highlights the role of modern materials science in developing antimicrobial surfaces and nanostructures that disrupt microbial adhesion and biofilm persistence. Furthermore, emerging therapeutic approaches such as antimicrobial peptides, engineered amphiphiles, and phage therapy are presented as promising alternatives to conventional antibiotics. The importance of diagnostics and surveillance in managing antimicrobial resistance (AMR), especially in low-resource settings, is emphasized. The paper concludes with a discussion on interdisciplinary collaboration as the foundation for engineering next-generation antimicrobial solutions and calls for sustained global innovation and policy alignment to combat the AMR crisis. Keywords: Antimicrobial resistance (AMR), microbial resistance, biofilms, nanotechnology, genetic adaptation, engineered surfaces, antimicrobial peptides, diagnostics, healthcare innovation.